Answers are grounded in this paper and cite their sources.
A case of a male with human immunodeficiency virus with plasma genotyping detecting no resistance and a CRF02_AG subtype had a controlled HIV RNA on antiretroviral therapy since 2010. We introduced intramuscular therapy with cabotegravir and rilpivirine. One month later, his HIV RNA was 1500 copies/mL; genotyping found a subtype B with many mutations.
No takes yet. Share an insight, caveat, or question.
Valin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: